Enya Amundsen-Isaksen

  • Dept. engineer; PhD
 

Publications 2026

Valestrand L, Nordhus KS, Claudel T, Øgaard J, Frank A, Amundsen-Isaksen E, Fuchs C, Berntsen NL, Chung BK, Jiang X, Trauner M, Melum E (2026)
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytes
Hepatol Commun, 10 (2)
DOI 10.1097/HC9.0000000000000862, PubMed 41543487

Publications 2022

Brinch SA, Amundsen-Isaksen E, Espada S, Hammarström C, Aizenshtadt A, Olsen PA, Holmen L, Høyem M, Scholz H, Grødeland G, Sowa ST, Galera-Prat A, Lehtiö L, Meerts IATM, Leenders RGG, Wegert A, Krauss S, Waaler J (2022)
The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models
Cancer Res Commun, 2 (4), 233-245
DOI 10.1158/2767-9764.CRC-22-0027, PubMed 36873622

Publications 2021

Leenders RGG, Brinch SA, Sowa ST, Amundsen-Isaksen E, Galera-Prat A, Murthy S, Aertssen S, Smits JN, Nieczypor P, Damen E, Wegert A, Nazaré M, Lehtiö L, Waaler J, Krauss S (2021)
Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II
J Med Chem, 64 (24), 17936-17949
DOI 10.1021/acs.jmedchem.1c01264, PubMed 34878777